SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-22-002834
Filing Date
2022-03-10
Accepted
2022-03-10 16:28:59
Documents
2
Period of Report
2022-03-07

Document Format Files

Seq Description Document Type Size
1 form3-03102022_010345.html 3  
1 form3-03102022_010345.xml 3 1752
2 ex24-03102022_010346.htm EX-24 6307
  Complete submission text file 0001415889-22-002834.txt   9442
Mailing Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 617-336-7540
Sigilon Therapeutics, Inc. (Issuer) CIK: 0001821323 (see all company filings)

IRS No.: 474005543 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O SIGILON THERAPEUTICS, INC. 100 BINNEY STREET, SUITE 600 CAMBRIDGE MA 02142
Business Address
Yuan Qing Sarah (Reporting) CIK: 0001907487 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39746 | Film No.: 22729422